Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype

Peiwei Zhao,Juan Huang,Huicong Fu,Jiali Xu,Tianhong Li,Xiankai Zhang,Qingjie Meng,Lei Zhang,Li Tan,Wen Zhang,Hebin Chen,Xiaoxia Lu,Yan Ding,Xuelian He
DOI: https://doi.org/10.1186/s12969-024-00955-7
2024-01-31
Pediatric Rheumatology
Abstract:Germline heterozygous gain-of-function (GOF) mutations in the PIK3CD gene lead to a rare primary immunodeficiency disease known as activated phosphoinositide 3-kinase (PI3K) δ syndrome type 1(APDS1). Affected patients present a spectrum of clinical manifestations, particularly recurrent respiratory infections and lymphoproliferation, increased levels of serum immunoglobulin (Ig) M, Epstein-Barr virus (EBV) and cytomegalovirus (CMV) viremia. Due to highly heterogeneous phenotypes of APDS1, it is very likely that suspected cases may be misdiagnosed.
pediatrics,rheumatology
What problem does this paper attempt to address?